YGR290W is part of the S. cerevisiae reference genome (strain S288C), with sequence data accessible via the Saccharomyces Genome Database (SGD) . Key aspects include:
Genomic location: Chromosome VII (YGR290W locus).
Protein function: No curated molecular function or biological process annotations are available in SGD, suggesting limited functional characterization .
Expression: Expression data derived from Gene Expression Omnibus (GEO) records indicate potential involvement in basic cellular processes .
The lack of interaction, regulation, or phenotype annotations in SGD highlights that YGR290W remains understudied compared to other yeast genes .
KO cell line testing: Recombinant antibodies often outperform traditional monoclonal/polyclonal types in Western blot (WB), immunoprecipitation (IP), and immunofluorescence (IF) assays .
Commercial antibody quality: A 2023 study found that ~50% of commercial antibodies fail to detect their intended targets in WB, underscoring the need for rigorous validation .
While YGR290W’s function is unclear, antibodies targeting yeast proteins are critical for studying cellular pathways, such as:
STRING: 4932.YGR290W
YGR290W is a systematic gene name in Saccharomyces cerevisiae that refers to a specific open reading frame on chromosome VII. The protein encoded by this gene plays roles in cellular processes that can be investigated through antibody-based techniques. Antibodies against YGR290W are crucial research tools that enable protein detection, localization studies, immunoprecipitation experiments, and functional analysis.
The importance of these antibodies stems from their ability to specifically recognize the YGR290W protein product among thousands of other cellular proteins. This specificity allows researchers to track the protein's expression levels, subcellular localization, post-translational modifications, and protein-protein interactions. Such information contributes to our understanding of fundamental biological processes in yeast, which often serve as models for similar processes in more complex eukaryotes including humans .
Validating antibody specificity is essential before conducting experiments. Several methodological approaches can be employed:
Western blot validation: Run protein extracts from wild-type yeast alongside YGR290W deletion strains. A specific antibody should show a band of the expected molecular weight in wild-type samples that is absent in the deletion strain. Include positive controls and molecular weight markers .
Immunoprecipitation followed by mass spectrometry: Perform immunoprecipitation with the YGR290W antibody and analyze the pulled-down proteins by mass spectrometry. The target protein should be prominently identified .
Immunofluorescence comparison: Perform immunofluorescence staining on both wild-type and YGR290W-tagged (e.g., GFP-tagged) strains. The antibody staining pattern should overlap with the fluorescent tag signal and be absent in deletion strains .
Dot blot analysis: Test antibody reactivity against purified YGR290W protein and unrelated control proteins to assess cross-reactivity.
For successful immunofluorescence detection of YGR290W in yeast cells, consider these methodological approaches:
Fixation protocol: Fix yeast cells with 4% paraformaldehyde in phosphate buffer for 15-20 minutes at room temperature. This preserves protein structure while maintaining cellular morphology. For membrane-associated proteins, adding 0.5% glutaraldehyde can improve antigen retention .
Cell wall digestion: Treat fixed cells with zymolyase (100 μg/ml) for 30 minutes at 30°C to create spheroplasts that allow antibody penetration through the cell wall.
Permeabilization methods: After fixation, permeabilize cells with either 0.1% Triton X-100 for 10 minutes or methanol/acetone (1:1) for 5 minutes at -20°C. The choice depends on the subcellular localization of YGR290W .
Blocking solution: Block non-specific binding sites with 2% BSA in PBS for 30 minutes before antibody incubation .
The optimal method may require empirical testing, as the accessibility of YGR290W epitopes can vary depending on its subcellular localization and conformational state.
Proper storage and handling are critical for maintaining antibody functionality:
Storage temperature: Store antibodies at -20°C for long-term preservation or at 4°C (with 0.02% sodium azide) for solutions in frequent use over 1-2 months.
Aliquoting strategy: Upon receipt, divide the antibody into small single-use aliquots (20-50 μl) to avoid repeated freeze-thaw cycles, which can denature antibody proteins and reduce activity.
Freezing protocol: Flash-freeze aliquots in liquid nitrogen before transferring to -20°C or -80°C storage to minimize ice crystal formation.
Working dilution preparation: When preparing working dilutions, use high-quality BSA (1-2%) as a carrier protein to prevent antibody adsorption to tube walls.
Contamination prevention: Always use sterile technique when handling antibodies, and include antimicrobial agents like sodium azide (0.02%) for solutions stored at 4°C.
Stability monitoring: Periodically test antibody activity against a standard sample to detect any deterioration in performance over time.
Following these guidelines helps maintain antibody specificity and sensitivity, ensuring consistent experimental results and maximizing the lifespan of valuable YGR290W antibody reagents.
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) with YGR290W antibodies requires careful optimization:
Crosslinking optimization: Test multiple formaldehyde concentrations (0.5-3%) and incubation times (10-30 minutes) to determine optimal crosslinking conditions that preserve protein-DNA interactions without overfixing, which can mask epitopes.
Sonication parameters: Optimize sonication conditions (amplitude, pulse duration, cycles) to achieve chromatin fragments of 200-500 bp. Monitor fragmentation efficiency using agarose gel electrophoresis.
Antibody titration: Perform preliminary ChIP experiments with different antibody amounts (1-10 μg per reaction) to determine the optimal concentration that maximizes signal-to-noise ratio.
Pre-clearing strategy: Implement a rigorous pre-clearing step using protein A/G beads and non-immune IgG to reduce background and increase specificity.
Sequential ChIP approach: For studying co-occupancy with other factors, consider sequential ChIP (re-ChIP) protocols where chromatin is immunoprecipitated first with YGR290W antibody followed by antibodies against suspected interaction partners.
Controls: Always include:
Input chromatin (non-immunoprecipitated)
IgG control (same species as YGR290W antibody)
Positive control regions (known binding sites)
Negative control regions (non-binding sites)
Spike-in normalization: Add a small amount (5%) of chromatin from a different species (e.g., Drosophila) with a species-specific antibody to allow for quantitative comparisons between different conditions or samples.
These methodological considerations help ensure reliable and reproducible ChIP-seq data when studying YGR290W's genomic interactions.
When encountering signal problems in Western blots, implement this systematic troubleshooting approach:
Protein expression verification:
First, confirm that YGR290W is expressed under your experimental conditions using RT-PCR or RNA-seq data. Expression might be condition-dependent or cell cycle-regulated .
Sample preparation optimization:
Add protease inhibitor cocktails to prevent degradation
Test different lysis buffers (RIPA, NP-40, Triton X-100) as buffer compatibility affects epitope accessibility
Avoid excessive heating during sample preparation (>70°C may cause protein aggregation)
Transfer efficiency assessment:
Use reversible protein stains (Ponceau S) to verify transfer efficiency
For high molecular weight proteins, extend transfer time or use specialized buffers with reduced methanol
Antibody optimization matrix:
| Parameter | Variables to Test |
|---|---|
| Primary antibody concentration | 1:500, 1:1000, 1:2000, 1:5000 |
| Incubation temperature | 4°C, Room temperature |
| Incubation time | 1 hour, overnight |
| Blocking agent | 5% milk, 3% BSA, commercial blockers |
| Detection system | ECL, ECL Plus, fluorescent secondary |
Epitope accessibility enhancement:
For membrane proteins, avoid reducing agents that disrupt disulfide bonds
Test different detergents in the blotting buffer (0.05-0.1% Tween-20 or 0.1% Triton X-100)
For conformational epitopes, use non-denaturing conditions
Signal amplification strategies:
HRP-polymer conjugated secondary antibodies
Biotin-streptavidin amplification systems
Tyramide signal amplification
Systematic testing of these variables should identify the optimal conditions for detecting YGR290W by Western blot.
Developing robust co-immunoprecipitation (co-IP) protocols for YGR290W requires careful consideration of multiple factors:
Lysis buffer selection: Test different lysis buffers to preserve protein-protein interactions:
For stable interactions: RIPA buffer with reduced detergent (0.1% NP-40)
For transient interactions: Milder NP-40 buffer (150 mM NaCl, 1% NP-40, 50 mM Tris pH 8.0)
For membrane-associated complexes: Digitonin-based buffers (1% digitonin, 150 mM NaCl, 50 mM Tris pH 7.4)
Crosslinking strategies: For capturing transient interactions, implement crosslinking:
Formaldehyde (0.1-1%) for short-range crosslinks
DSS or DSP (0.5-2 mM) for longer-range crosslinks
Photo-activated crosslinkers for controlled spatiotemporal crosslinking
Pull-down approaches:
Direct antibody immobilization on activated beads to reduce background
Compare results using N- and C-terminal antibodies as epitope accessibility may differ in complexes
Sequential immunoprecipitation for specific subcomplexes
Control experiments:
IgG control (same species as YGR290W antibody)
Reciprocal IP with antibodies against suspected partners
IP from YGR290W deletion strains
Competition with purified antigens
Mass spectrometry sample preparation:
On-bead digestion to minimize contaminants
Gentle elution methods (low pH, peptide competition)
Crosslink-compatible digestion protocols if using crosslinkers
Validation strategies:
Targeted Western blot for suspected interaction partners
Proximity ligation assays to confirm interactions in situ
Functional assays to establish biological relevance of interactions
These methodological considerations help establish specific and biologically meaningful protein interaction networks for YGR290W.
Optimizing immunohistochemistry (IHC) for YGR290W detection in yeast samples requires specialized approaches:
Sample preparation:
Fix yeast cells with 4% paraformaldehyde combined with 0.5% glutaraldehyde for 20 minutes at room temperature
For embedding, gradually dehydrate cells and infiltrate with paraffin or optimal cutting temperature (OCT) compound
Section yeast samples at 2-4 μm thickness for optimal resolution
Antigen retrieval methods:
Heat-induced epitope retrieval: Citrate buffer (pH 6.0) at 95°C for 15-20 minutes
Enzymatic retrieval: Proteinase K (20 μg/ml) for 10-15 minutes at 37°C
Carefully optimize time to prevent over-digestion of small yeast cells
Signal amplification systems:
Tyramide signal amplification can increase sensitivity 10-50 fold
Polymer-based detection systems reduce background compared to avidin-biotin systems
Quantum dots or fluorescent nanoparticles for multiplex detection
Controls and validation:
YGR290W deletion strains as negative controls
GFP-tagged YGR290W strains for comparative localization
Peptide competition assays to confirm specificity
Dual labeling with organelle markers to confirm subcellular localization
Imaging considerations:
Super-resolution microscopy techniques (STED, STORM) for precise localization
Spectral unmixing for multi-label experiments
Deconvolution algorithms to improve signal-to-noise ratio
These methodological refinements allow for sensitive and specific detection of YGR290W in yeast samples, providing valuable insights into its subcellular localization and expression patterns.
Generating effective phospho-specific antibodies against YGR290W requires strategic planning:
Phosphorylation site identification:
First analyze YGR290W sequence using phosphorylation prediction algorithms (NetPhos, GPS)
Confirm sites through mass spectrometry analysis of purified YGR290W protein
Prioritize evolutionarily conserved sites that may have functional significance
Peptide design criteria:
Design 10-15 amino acid peptides centered around the phosphorylated residue
Include a C-terminal cysteine for conjugation if not naturally present
Consider synthesizing both phosphorylated and non-phosphorylated versions of each peptide
Carrier protein selection:
KLH (keyhole limpet hemocyanin) for robust immune response
BSA for ELISA and other analytical applications
Use maleimide chemistry for directed conjugation through cysteine residues
Immunization protocol:
Use multiple rabbits (minimum 2-3) per phospho-peptide
Implement a longer immunization schedule (12-16 weeks) for high-affinity antibodies
Monitor antibody titer development through ELISA against both phospho and non-phospho peptides
Purification strategy:
| Step | Method | Purpose |
|---|---|---|
| 1 | Protein A/G affinity | Isolate total IgG |
| 2 | Non-phospho peptide column | Remove antibodies recognizing backbone |
| 3 | Phospho-peptide affinity | Enrich phospho-specific antibodies |
| 4 | Validation using phosphatase-treated samples | Confirm specificity |
Validation experiments:
Western blot comparing untreated vs. phosphatase-treated samples
Immunoprecipitation followed by phospho-specific staining
Peptide competition assays with phospho and non-phospho peptides
Testing on samples with stimulated vs. inhibited relevant kinase pathways
This comprehensive approach maximizes the chances of generating highly specific phospho-antibodies for studying YGR290W regulation.
Designing quantitative assays for YGR290W protein levels involves several methodological considerations:
ELISA development:
Sandwich ELISA using two antibodies recognizing different epitopes
Coat plates with capture antibody (1-10 μg/ml) in carbonate buffer (pH 9.6)
Block with 2-5% BSA or commercial blocking buffers for 1-2 hours
Use calibration curves with recombinant YGR290W protein (5-point dilution series)
Optimize primary and secondary antibody concentrations through checkerboard titration
Western blot quantification:
Include recombinant YGR290W standards at known concentrations
Use fluorescent secondary antibodies for wider linear dynamic range
Implement GAPDH or actin loading controls for normalization
Analyze bands using densitometry software with background subtraction
Apply statistical methods to account for gel-to-gel variation
Flow cytometry analysis:
Fix and permeabilize yeast cells with 70% ethanol or 0.1% Triton X-100
Optimize antibody concentration and incubation time for intracellular staining
Include isotype controls to establish background fluorescence levels
Use mean fluorescence intensity (MFI) for quantitative comparisons
Consider bead-based standards for absolute quantification
Capillary electrophoresis immunoassay:
Separate proteins based on size in capillaries
Detect with antibody-HRP conjugates or fluorescent antibodies
Achieve higher throughput and reproducibility than traditional Western blots
Implement automated analysis for greater precision
Mass spectrometry-based quantification:
Develop selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) assays
Synthesize isotope-labeled peptide standards for absolute quantification
Target 2-3 unique peptides from YGR290W for redundant measurement
Monitor multiple transitions per peptide for increased specificity
These quantitative approaches provide complementary data on YGR290W protein expression levels across different experimental conditions, enabling robust comparative analyses .